The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quality of life (QOL) measurement in patients receiving neoadjuvant therapy in the I-SPY 2 trial.
Michael Hwang
No relevant relationships to disclose
Roxanne E Jensen
No relevant relationships to disclose
Julia Lyandres
No relevant relationships to disclose
Jane Perlmutter
No relevant relationships to disclose
I-SPY 2 Trial Coordinators and Research Nurses
No relevant relationships to disclose
Laura Esserman
No relevant relationships to disclose
Michelle E. Melisko
No relevant relationships to disclose